Page 2 - Pfizer Global Product Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

CellCentric Receives $25M Strategic Investment from Pfizer

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

United kingdomAstrid ruefli brassePfizer global product developmentDevelopment headUniversity of cambridgePfizer worldwide research developmentUnited kingdom basedPfizer igniteProfessor azim suraniVice presidentTumour biologyPfizer worldwide researchScientific advisory boardMultiple myeloma

Caribou Biosciences Announces $25 Million Equity Investment from Pfizer

Pfizer purchases $25 million of Caribou common shares

United statesPeggy vorwaldSriram krishnaswamiSamy figueroaRachel haurwitzExchange commissionPfizer global product developmentCaribou biosciences incPfizer incScientific advisorySecurities purchase agreementSecurities actRegenerative medicine advanced therapyFast trackOrphan drugCaribou biosciences

Fidanacogene Elaparvovec, a Gene Therapy for Hemophilia B, Under Review

The FDA has accepted for review the BLA for fidanacogene elaparvovec for the treatment of adults with hemophilia B.

Chris boshoffDrug administrationPfizer global product developmentBiologic license applicationChief development officerRare diseasePfizer global productPrescription drug user fee act

FDA Accepts Pfizer s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec

FDA Accepts Pfizer s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Chris boshoffPfizer global product developmentPfizer incWorld federation of hemophiliaEuropean medicines agencyCenters for diseaseExchange commissionDrug administrationBiologics license applicationChief development officerRare diseasePfizer global productPrescription drug user fee actRegenerative medicines advanced therapyWorld federationChange patient

FDA Accepts Pfizer s Application for Hemophilia B Gene Therapy Fidanacogene Elaparvovec | Business

NEW YORK (BUSINESS WIRE) Jun 27, 2023

United statesChris boshoffDrug administrationExchange commissionEuropean medicines agencyCenters for diseasePfizer incPfizer global product developmentWorld federation of hemophiliaBiologics license applicationChief development officerRare diseasePfizer global productPrescription drug user fee actRegenerative medicines advanced therapyWorld federation